mogamulizumab

CHEBI:CHEBI_752604

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
mogamulizumab
listing_expiration_date
20251231
dosage_form
INJECTION
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
marketing_start_date
20180808
labeler_name
Kyowa Kirin Co., Ltd.
product_ndc
45793-0201
spl_id
3fcc4575-687b-46cc-9972-f065907700a1
active_ingredient_name
MOGAMULIZUMAB
active_ingredient_strength
9.5 g/L
package_ndc
45793-0201-1
package_description
1.6 L in 1 BOTTLE (45793-0201-1)
package_marketing_start_date
08-AUG-18
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class